We are pleased to announce that two other French clinical centres have been involved in the GABA-1 study. The GABA-1 study has already been approved by the Ethics Committee (Comite de Protection des Personnes – Ile de France 1) in France, while the approval of the medicines agency (Agence nationale de sécurité du médicament et des produits de santé – ANSM) is expected very soon, as all the questions raised by the ANSM will be satisfied within the first week of August 2016.
We warmly welcome the two Principal Investigators of the following centres, that will start screening patients in the very next few months:
Their patients will be enrolled at the Center of Clinical Investigations of the Hôpital Robert Debré Assistance Publique Hôpitaux de Paris – APHP.
We take this occasion to wish all of you happy summer holidays!
